Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-26

Clinical Trial Update: Efficacy, Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment Premature Ejaculation [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports on the efficacy, safety and tolerability of PSD502, a topical anesthetic, for treating premature ejaculation, with Phase 2 an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PSD502

Snippet

Sponsor: Plethora Solutions Ltd | Conditions: Premature Ejaculation | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2016-09-26